
TransMedics Group (TMDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2026) a publié ses dernières prévisions le $737M - $757M pour TransMedics Group {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
Par rapport aux prévisions précédentes, {{newestDate}} {{directionSummary}} ses prévisions de chiffre d'affaires ont été revues à la baisse, passant d'une fourchette précédente de undefined à undefined.
undefined a publié undefined mises à jour de ses recommandations entre undefined et undefined. undefined
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.52 | $0.61 | $0.39 | $0.36 |
| Actual | $0.44 | $0.30 | $0.57 | $0.66 |
| Surprise | -15.4% | -50.8% | +46.2% | +83.3% |
| Revenue | ||||
| Estimate | $184.1M | $174.4M | $155.3M | $144.8M |
| Actual | $189.9M | $173.9M | $160.8M | $143.8M |
| Surprise | +3.20% | -0.26% | +3.50% | -0.69% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.29 | $0.48 | $0.53 | $0.60 |
| Revenue | ||||
| Consensus | $178.0M | $201.0M | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.44 | $0.52 | -15.4 % |
| Q1 | May 5, 2026 | $0.30 | $0.61 | -50.8 % |
| Q4 | Feb 24, 2026 | $0.57 | $0.39 | 46.2 % |
| Q3 | Oct 29, 2025 | $0.66 | $0.36 | 83.3 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $189.95M | $184.06M | 3.20 % |
| Q1 | May 5, 2026 | $173.93M | $174.38M | -0.26 % |
| Q4 | Feb 24, 2026 | $160.76M | $155.33M | 3.50 % |
| Q3 | Oct 29, 2025 | $143.82M | $144.83M | -0.69 % |